Annual report pursuant to Section 13 and 15(d)

Stock-Based Compensation - Stock Options Narrative (Details)

v3.24.0.1
Stock-Based Compensation - Stock Options Narrative (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Stock Option Disclosures      
Intrinsic value of options exercised $ 1,710 $ 2,643 $ 14,167
Weighted average period of recognition of unrecognized compensation expense 2 years 3 months 18 days    
Prior Axogen Plan | Minimum      
Stock Option Disclosures      
Vesting period (in years) 7 years    
Prior Axogen Plan | Maximum      
Stock Option Disclosures      
Vesting period (in years) 10 years    
Stock options      
Stock Option Disclosures      
Weighted average grant date fair value (in dollars per share) $ 4.72 $ 4.65 $ 10.53
Unrecognized compensation costs related to non-vested stock options and restricted stock awards $ 6,414    
Stock options | Prior Axogen Plan      
Stock Option Disclosures      
Vesting period (in years) 4 years    
Stock options | Prior Axogen Plan | One Year After Grant Date      
Stock Option Disclosures      
Vesting percentage 25.00%    
Vesting period (in years) 1 year    
Stock options | Prior Axogen Plan | Tranche Two      
Stock Option Disclosures      
Vesting percentage 12.50%    
Vesting period (in years) 3 years    
Stock options | 2017 ESPP      
Stock Option Disclosures      
Vesting period (in years) 4 years    
Stock options | 2017 ESPP | Tranche Two      
Stock Option Disclosures      
Vesting percentage 12.50%    
Vesting period (in years) 2 years    
Stock options | 2017 ESPP | Tranche One      
Stock Option Disclosures      
Vesting percentage 50.00%    
Vesting period (in years) 2 years    
Directors And Officers Stock Options | Per Quarter, Over One Year      
Stock Option Disclosures      
Vesting percentage 25.00%    
Vesting period (in years) 1 year    
Directors And Officers Stock Options | 2017 ESPP      
Stock Option Disclosures      
Vesting period (in years) 3 years